New Funding Dean's List

Notable & novel scientific awards to celebrate. All New Funding Awards can be viewed here

2018: July, August, September

SEPTEMBER 2018 

New Federal Awards

Joe Cullen & Doug Spitz  •  Surgery & Rad Onc
Exploiting Redox Metabolism Using Pharmacological Ascorbate for Cancer Therapy 
NIH P01  •  5 years

Joseph Buckwalter  •  Orthopedics & Rehabilitation
Translating Metabolic Responses to Mechanical Insult into Early Interventions to Prevent PTOA
US Department of Defense

Paul McCray  •  Pediatrics
CRISPR Ribonucleoproteins to Airway Epithelia Using Novel Amphiphilic Peptides  
NIH UG3  •  3 years

Hai-Hai Xue  •  Microbiology
Ezh2 regulates follicular helper T cell differentiation 
NIH R01  •  5 years

Chris Adams  •  Internal Medicine
Novel signaling pathways underlying skeletal muscle atrophy
NIH R01  •  5 years

David Weiss  •  Microbiology
Peptidoglycan binding protein specificity and bacterial cell division 
NIH R01  •  4 years

Georgina Aldridge  •  Neurology
Cortical Mechanisms in Lewy Body Dementia 
NIH K08  •  5 years

Mitchell Coleman  •  Radiation Oncology
Do Changes in Thiol Metabolism Mediate Osteoarthritis Progression? 
NIH R00  •  3 years

Peg Nopoulos  •  Psychiatry
Transfusion of Prematurity Early School Age Follow-up (TOP 5) CCC  
NIH UG3  •  1 year

Jeffrey Segar  •  Pediatrics
Fenoldopam to prevent renal dysfunction in indomethacin treated preterm infants  
NIH R21  •  2 years

Sharon Idiga  •  Pharmacology
Endocrine Circuit Regulating Sugar Satiety 
NIH F31  •  2 years

Alexander Greiner  •  Internal Medicine
MSX1 in Cardiac Fibrosis and Sudden Death  
NIH F30  •  4 years

Competitive Renewals

David Stoltz  •  Internal Mediciner
Origins of Cystic Fibrosis Airway Disease  
NIH P01  •  5 years

Rob Cornell  •  Anatomy & Cell Biology
Dissecting the transcriptional network governing differentiation of periderm
NIH R56  •  1 year

Todd Washington  •  Biochemistry
Mechanisms of Damaged DNA Replication in Eukaryotes 
NIH R01  •  4 years

Clinical Trial Support

Steven Polyak  •  Internal Medicine
Upadacitinib (ABT-494) in Subjects with Crohn's Disease
AbbVie Inc.

Randy Loftus  •  Anesthesia
Reducing Perioperative S. aureus Transmission
Anesthesia Patient Safety Foundation

Mo Milhem  •  Internal Medicine
DSP-7888 Dosing in Combination with Immune Checkpoint Inhibitors in Adult Subjects with Advanced Solid Tumors
INC Research, LLC

Steven Lentz  •  Internal Medicine
Pathfinder 8
Novo Nordisk, Inc.

Kirill Nourski  •  Neurosurgery
Mechanisms of anesthetic-induced unconsciousness
University of Wisconsin-Madison

 

AUGUST 2018 

New Federal Awards

Enrique Leira  •  Neurology
UI Regional Stroke Research Network 
NIH U21  •  5 years

Robert Weiss  •  Internal Medicine
Injury in Calcific Aortic Valve Disease
NIH R01  •  4 years

Stephen Hillis  •  Radiology
Generalized Obuchowski-Rockette Methodology for Analysis of Radiologic Diagnostic Imaging
NIH R01  •  4 years

Michael Anderson  •  Physiology
Genetic modifiers of Cep290-mediated retinal degeneration  
NIH R21  •  2 years

Rudragouda Channappanavar  •  Microbiology
Interferon lambda in host protection during aging 
NIH R21  •  2 years

Ali Jabbari  •  Dermatology
Defining T helper cell associated cytokines and mechanisms in Alopecia Areata   
NIH K08  •  3 years

Competitive Renewals

Rob Cornell  •  Anatomy & Cell Biology
Regulation of the Melanocyte Lineage by the AP2 Transcription Factor Family
NIH R01  •  5 years

Rob Piper  •  Physiology
Ubiquitin-dependent sorting in endosomes and the TGN
NIH R01  •  4 years

Clinical Trial Support

Steven Polyak  •  Internal Medicine
Upadacitinib (ABT-494) in Subjects with Moderately to Severely Active Crohn's Disease
AbbVie, Inc

Mark Santillan  •  Obstetrics & Gynecology
Mechanisms of Early and Late Postpartum Hypertension in Human Preeclampsia
American Heart Association

Huy Tran  •  Internal Medicine
Obeticholic Acid in Subjects with Cirrhosis
Intercept Pharmaceuticals, Inc.

Michael Ohl  •  Internal Medicine
Public Health-Partnered Tele-Medical Pre-Exposure Prophylaxis Delivery in a Rural State
Iowa Department of Public Health

Sneha Deepak Phadke  •  Internal Medicine
Alpelisib plus fulvestrant or letrozole in patients with PIK3CA
Novartis

Muhammad Furqan  •  Internal Medicine
First-Line Therapy in Patients with Metastatic NSCLC
Pharmaceutical Research Associates

 

JULY 2018 

New Federal Awards

Dan Weeks  •  Biochemistry
Amyloids, aggregates and nucleolar activity in Xenopus development
NIH R01  •  4 years

Frank Faraci  •  Internal Medicine
Central RAAS and Brain Small Vessel Disease
NIH R01  •  5 years

Robert Block  •  Anesthesia
General Anesthesia During Early Childhood and Brain Development 
NIH R01  •  5 years

Wendy Maury  •  Microbiology
Modeling Filovirus Infection of and Trafficking through Skin  
NIH R01  •  4 years

Catherine Musselman  •  Biochemistry
Molecular mechanisms of histone signaling in a chromatin relevant context  
NIH R35  •  5 years

Adam Dupuy  •  Anatomy & Cell Biology
The role germline polymorphisms on ALL susceptibility  
NIH R21  •  2 years

Bradley Erickson  •  Urology
Understanding the Role of Local & Systemic Inflammation in Male Urethral Stricture Disease  
NIH R21  •  2 years

Rebecca Dodd  •  Internal Medicine
Mechanisms of NF1+/- Myeloid Cell Function in MPNSTs
US Department of Defense

Loreen Herwaldt  •  Internal Medicine
SHEPheRD RFTOP 2018 Domain-1-A001
US Dept of HHS 

Laurie Gutmann, Harold Adams, Nandakumar Narayanan, Mike Shy, Katherine Matthews & Peggy Nopoulos  •  Neurology, Pediatrics & Psychiatry
University of Iowa's NeuroNEXT Clinical Research Site   
NIH U24  •  5 years

Competitive Renewals

John Harty  •  Microbiology
Understanding immune regulation in blood-stage malaria
NIH R01  •  4 years

Clinical Trial Support

Mony Fraer  •  Internal Medicine
OMS721 in Patients with Immunoglobulin A (IgA) Nephropathy
Omeros Corporation

Mo Milhem  •  Internal Medicine
UV1 Vaccine in First-Line Malignant Melanoma Patients
Ultimovacs AS